# FDA Inspection 961300 - Dendreon Pharmaceuticals LLC - January 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/be5c77a3-ea81-4d35-a080-b28478e98252
Source feed: FDA_Inspections

> FDA Inspection 961300 for Dendreon Pharmaceuticals LLC on January 22, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 961300
- Company Name: Dendreon Pharmaceuticals LLC
- Inspection Date: 2016-01-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1214688 - 2023-08-10](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/4fe7a753-79ef-4ea0-be81-129f0bb9e16c)
- [FDA Inspection 1109236 - 2019-11-08](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/54955f40-a4c2-4bc9-981a-fc18dba66ec3)
- [FDA Inspection 1038072 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/c7e1845f-cb5b-449a-9b17-557e9b813d17)
- [FDA Inspection 848259 - 2012-11-15](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/d1df774c-a627-4c18-89ed-7cb027877c03)

Company: https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d